24 April 2025 - The Public Summary Documents (first-time decisions not to recommend and deferrals) from the December 2024 PBAC meeting ...
24 April 2025 - Recommendations made by the PBAC in March 2025 relating to the listing of medicines on the PBS ...
22 April 2025 - The EMA has published a draft agenda for this week's CHMP meeting. ...
11 April 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the December 2024 PBAC ...
2 April 2025 - The agenda for the July 2025 PBAC meeting is now available. ...
24 March 2025 - The EMA has published a draft agenda for this week's CHMP meeting. ...
26 March 2025 - There are significant uncertainties regarding long term efficacy and durability of sonpiretigene isteparvovec; ICER estimates that ...
21 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...
14 March 2025 - The utilisation analysis public release documents from the October 2024 DUSC meeting are now available. ...
7 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...
24 February 2025 - The EMA has published a draft agenda for this week's CHMP meeting. ...
6 February 2025 - Public comment period now open until 6 March 2025; requests to make oral comment during public ...
5 February 2025 - Current evidence suggests that suzetrigine may provide a net health benefit when compared to no systemic ...
27 January 2025 - The EMA has published a draft agenda for this week's CHMP meeting. ...
20 December 2024 - At its September 2024 meeting, the PBAC considered a report presenting a utilisation analysis of PBS ...